Jane Street’s Carisma Therapeutics CARM Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $59.1K | Buy |
+150,810
| New | +$59.1K | ﹤0.01% | 5073 |
|
|
2024
Q3 | – | Sell |
-159,879
| Closed | -$243K | – | 5966 |
|
|
2024
Q2 | $243K | Buy |
+159,879
| New | +$243K | ﹤0.01% | 5227 |
|
|
2023
Q4 | – | Sell |
-36,328
| Closed | -$154K | – | 5744 |
|
|
2023
Q3 | $154K | Buy |
36,328
+230
| +0.6% | +$973 | ﹤0.01% | 4499 |
|
|
2023
Q2 | $317K | Buy |
+36,098
| New | +$317K | ﹤0.01% | 4206 |
|
|
2023
Q1 | – | Sell |
-14,250
| Closed | -$174K | – | 5624 |
|
|
2022
Q4 | $174K | Buy |
+14,250
| New | +$174K | ﹤0.01% | 4467 |
|
|
2022
Q3 | – | Sell |
-6,018
| Closed | -$98K | – | 5782 |
|
|
2022
Q2 | $98K | Buy |
6,018
+5,007
| +495% | +$81.5K | ﹤0.01% | 4749 |
|
|
2022
Q1 | $12K | Sell |
1,011
-22,253
| -96% | -$264K | ﹤0.01% | 5439 |
|
|
2021
Q4 | $379K | Sell |
23,264
-22,942
| -50% | -$374K | ﹤0.01% | 3767 |
|
|
2021
Q3 | $733K | Buy |
46,206
+32,287
| +232% | +$512K | ﹤0.01% | 3006 |
|
|
2021
Q2 | $1.29M | Buy |
13,919
+6,190
| +80% | +$572K | ﹤0.01% | 2263 |
|
|
2021
Q1 | $401K | Buy |
7,729
+5,766
| +294% | +$299K | ﹤0.01% | 3596 |
|
|
2020
Q4 | $53K | Sell |
1,963
-4,625
| -70% | -$125K | ﹤0.01% | 3729 |
|
|
2020
Q3 | $184K | Buy |
6,588
+5,534
| +525% | +$155K | ﹤0.01% | 3259 |
|
|
2020
Q2 | $15K | Buy |
+1,054
| New | +$15K | ﹤0.01% | 3884 |
|
|
2019
Q3 | – | Sell |
-1,603
| Closed | -$48K | – | 3456 |
|
|
2019
Q2 | $48K | Buy |
+1,603
| New | +$48K | ﹤0.01% | 3376 |
|
|
2019
Q1 | – | Sell |
-1,429
| Closed | -$41K | – | 3309 |
|
|
2018
Q4 | $41K | Buy |
+1,429
| New | +$41K | ﹤0.01% | 3047 |
|